Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robots take on throat cancer: early results show promise

NCT ID NCT01257633

Knowledge-focused Sponsor: Centre Hospitalier Universitaire de Nīmes Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at how well robot-assisted surgery removes early-stage laryngeal cancer. 54 patients had their tumors removed using a da Vinci robot. The main goal was to see how often the surgery got all the cancer out (clear surgical margins). The study also tracked surgery time and complications.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Transoral robot-assisted tumor resection using the da Vinci robot
What this could lead to
If successful, this could show that robot-assisted surgery is a reliable way to remove early-stage laryngeal cancer with clear margins.
What could go wrong
This is a small, completed observational study, not a randomized trial. It only measures surgical margins, not long-term survival or recurrence.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

54 people

The number who actually took part.

Start date

Apr 2011

Finished

Sep 2014

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

This study is aimed at all patients with early stage (T1 or T2) glottic and / or supraglottic squamous cell carcinoma of the larynx, whatever their status and cervical lymph nodes without distant metastases (M0) and for whom endoscopic surgical treatment with robotic assistance is indicated following a multidisciplinary meeting.

Ages

18 to 90 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * The subject has signed consent * The subject must be a member or beneficiary of a health insurance plan * The patient is available for 12 months of follow-up * The subject has a cancer of the larynx: * classified T1 or T2 in the TNM * glottic localization and / or supraglottic regardless of node status * with or without a history of head and neck cancer * The subject does not have distant metastasis (M0) * A decision for endoscopic robot-assisted surgery is retained in multidisciplinary meeting Exclusion Criteria: \-

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Glottic laryngeal cancer are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

glottis carcinoma laryngeal neoplasm supraglottis cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Laryngeal neoplasms

Contacts and locations

Locations

  • CHRU de Toulouse - Hôpital de Rangueil

    Toulouse, 31059, France

  • CHU de Montpellier - Hôpital Gui de Chauliac

    Montpellier, 34295, France

  • CHU de Nîmes - Hôpital Universitaire Carémeau

    Nîmes, Gard, 30029, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.